Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events.
about
Toxicity management of immunotherapy for patients with metastatic melanomaGastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors.Checkpoint modulation in melanoma: an update on ipilimumab and future directions.Infectious Colitis Associated With Ipilimumab Therapy.Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor TherapySystematic review: colitis associated with anti-CTLA-4 therapy.Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.Immunotherapy for breast cancer: past, present, and future.Biomarkers associated with checkpoint inhibitors.Immune checkpoint inhibitors side effects and management.Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.Meta-analysis of the risk of immune-related adverse events with anti-cytotoxic T-lymphocyte-associated antigen 4 and anti-programmed death 1 therapies.CEACAM1 as a multi-purpose target for cancer immunotherapy.Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.Informatics for cancer immunotherapy.Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis.Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm.Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors.[The pathology of adverse events with immune checkpoint inhibitors].Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice.Clinical assessment of immune-related adverse events.Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors.A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumabPredictors of immunotherapy-induced immune-related adverse events
P2860
Q26738662-AF3A5059-C00F-45CF-B340-527AF089FC24Q36260666-99A224F5-2666-4D3E-BD19-7A38D8E9457BQ37237761-DA6EC00E-0BB4-433F-8815-DF3860A044BEQ37311734-F5BAFE8B-E0F7-4A8B-9C82-BF8937B3B248Q37629874-FFC29CA7-FA37-419C-B66C-BFBC49820323Q38529051-95C8EAFE-4853-482A-BB7C-075CFAC37E46Q38654099-2656A4C5-A463-443D-9612-84831336E841Q38787696-86AA7878-5FE1-4070-9B43-F6F8A277425AQ38819537-3C78C8A3-E145-43B4-968C-8B4853B5B84CQ38878899-656BABC7-E541-4E01-8B39-DBBA12F1B8A3Q38950036-7E25160C-BA70-41FA-B8D1-29D8B7C1E17DQ39009781-A2506ECA-C3E2-4CEF-B536-74A1407A8E59Q39101223-719DEC04-C3E1-496E-B54F-64B98DFF33A5Q41251368-D455BFBE-C1A9-435A-840A-203EB220E3C4Q47101079-A5C5A06A-7D3B-4FB6-A3E5-CED7B80FB5C5Q47290509-BA729261-C2BB-47ED-BB24-A441B5694BE5Q47692659-821F76F3-3224-4689-8055-BDD5FEBCA753Q50719439-C8B6EA37-4CA4-410C-86DE-ACF36D8F0486Q52615452-B4730873-7AF2-4276-B404-7D034A6328FCQ52879625-64B4EAE9-F39E-460A-A28A-785010D81EA3Q53695267-1DE1F9C9-2024-4423-990E-C0FB7FB79F38Q55292659-5BEEA898-8D69-4408-ACB0-73C99DF20897Q55314300-AF006F98-E96A-4986-A871-06D9F2B12CB7Q56888756-700E7A4C-A8EE-4B73-9ED1-3271FBC73990Q59135410-6E630BF1-3A32-445E-B04D-F7464A1FC34F
P2860
Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Gene expression profiling of w ...... strointestinal adverse events.
@en
type
label
Gene expression profiling of w ...... strointestinal adverse events.
@en
prefLabel
Gene expression profiling of w ...... strointestinal adverse events.
@en
P2093
P2860
P356
P1476
Gene expression profiling of w ...... strointestinal adverse events.
@en
P2093
Beihong Hu
David Berman
Lisa Panting
Maria Jure-Kunkel
Scott D Chasalow
Vafa Shahabi
Zenta Tsuchihashi
P2860
P2888
P356
10.1186/1479-5876-11-75
P577
2013-03-22T00:00:00Z
P5875
P6179
1044328440